News brief­ing: Fre­quen­cy posts ex­tend­ed pos­i­tive re­sults for hear­ing loss pro­gram; Kiniksa earns ODD for GCA can­di­date

Fre­quen­cy Ther­a­peu­tics pre­sent­ed re­sults from a longer-term dura­bil­i­ty study of its ac­quired sen­sorineur­al hear­ing loss can­di­date, say­ing FX-322 showed sig­nif­i­cant …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER